1. Wang, Wei, Zheng, Yuxuan, Sun, Shuhui, Tang, Fuchou, Liu, Guang-Hui. . A genome-wide CRISPR-based screen identifies KAT7 as a driver of cellular senescence. In Science translational medicine, 13, . doi:10.1126/scitranslmed.abd2655. https://pubmed.ncbi.nlm.nih.gov/33408182/
2. Yuan, Quan, Wu, Yuxuan, Xue, Cheng, Wang, Haibo, Shen, Yixin. 2024. KAT7 serves as an oncogenic gene and regulates CCL3 expression via STAT1 signaling in osteosarcoma. In Biochemical and biophysical research communications, 722, 150156. doi:10.1016/j.bbrc.2024.150156. https://pubmed.ncbi.nlm.nih.gov/38797155/
3. Kueh, Andrew J, Bergamasco, Maria I, Quaglieri, Anna, Thomas, Tim, Voss, Anne K. 2023. Stem cell plasticity, acetylation of H3K14, and de novo gene activation rely on KAT7. In Cell reports, 42, 111980. doi:10.1016/j.celrep.2022.111980. https://pubmed.ncbi.nlm.nih.gov/36641753/
4. Yang, Yuqing, Kueh, Andrew J, Grant, Zoe L, Voss, Anne K, Thomas, Tim. . The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal. In Blood, 139, 845-858. doi:10.1182/blood.2021013954. https://pubmed.ncbi.nlm.nih.gov/34724565/
5. Lancho, Olga, Singh, Amartya, da Silva-Diz, Victoria, Khiabanian, Hossein, Herranz, Daniel. . A Therapeutically Targetable NOTCH1-SIRT1-KAT7 Axis in T-cell Leukemia. In Blood cancer discovery, 4, 12-33. doi:10.1158/2643-3230.BCD-22-0098. https://pubmed.ncbi.nlm.nih.gov/36322781/
6. Wang, Hao, Qiu, Yingqi, Zhang, Honghao, Xie, Xiaoling, Li, Yuhua. 2023. Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia. In Cell death & disease, 14, 498. doi:10.1038/s41419-023-06019-0. https://pubmed.ncbi.nlm.nih.gov/37542030/
7. Lu, Ying, Wang, Yong, Zhang, Leilei, Du, Yimeng, Li, Qihong. 2024. KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA. In Cancer letters, 590, 216869. doi:10.1016/j.canlet.2024.216869. https://pubmed.ncbi.nlm.nih.gov/38593918/